Skip to contentThunen Shelley B — INTRALASE CORP insider: 177 transactions · InsiderLensThunen Shelley B
- Director at AEON Biopharma, Inc. · on record since Jul 24, 2023
- See remarks at RxSight, Inc. · on record since Jul 29, 2021
- Chief Financial Officer at ENDOLOGIX INC /DE/ · on record since Jan 4, 2013
- Director at LENZ Therapeutics, Inc. · on record since Jun 15, 2026
- CFO, Treasurer & Asst. Sec'ty at INTRALASE CORP · on record since Oct 6, 2004
- Named Executive Officer at ENDOLOGIX INC /DE/ · on record since Oct 21, 2015
- Director at Equinox International, Inc. · on record since Oct 11, 2017
Insider trading activity of Thunen Shelley B
- Transactions on record
- 177
- since Apr 28, 2005
- Open-market buys
- 0
- Open-market sells
- 104
- $9.6M
- Companies traded
- 6
- last filing Jun 22, 2026
Figures computed from official regulatory filings — methodology.
Companies where Thunen Shelley B has traded
- AEON Biopharma, Inc.6 tx · Jun 22, 2026
- LENZ Therapeutics, Inc.3 tx · Jun 15, 2026
- RxSight, Inc.59 tx · $10.7M · Apr 15, 2025
- Equinox International, Inc.1 tx · Jun 15, 2018
- ENDOLOGIX INC /DE/12 tx · $75.1K · Oct 21, 2015
- INTRALASE CORP96 tx · $6.5M · Apr 4, 2007
Track record of Thunen Shelley B
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Thunen Shelley B
Co-insiders of Thunen Shelley B
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Lightman JamesAEON Biopharma, Inc. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 22, 2026 | Award | 222,684 | 0.00 USD | — | SEC |
| Jun 15, 2026 | AwardD | 22,100 | 0.00 USD | $0 | SEC |
| Jun 11, 2025 | AwardD | 13,500 | 0.00 USD | $0 | SEC |
| May 23, 2025 | AwardD | 308,641 | 0.00 USD | $0 | SEC |
| Apr 15, 2025 | ExerciseD | -1,387 | 0.00 USD | $0 | SEC |
| Apr 15, 2025 | ExerciseD | -6,405 | 0.00 USD | $0 | SEC |
| Apr 15, 2025 | Exercise | 7,792 | 4.34 USD | $33.8K | SEC |
| Feb 27, 2025 | AwardD | 125,000 | 0.00 USD | $0 | SEC |
| Oct 2, 2024 | ExerciseD | -15,000 | 0.00 USD | $0 | SEC |
| Oct 2, 2024 | Sell | -5,201 | 47.96 USD | $249.4K | SEC |
| Oct 2, 2024 | Sell | -278 | 49.45 USD | $13.7K | SEC |
| Oct 2, 2024 | Sell | -9,521 | 48.69 USD | $463.6K | SEC |
| Oct 2, 2024 | Exercise | 15,000 | 16.00 USD | $240K | SEC |
| Sep 4, 2024 | Award | 36,021 | 0.00 USD | $0 | SEC |
| Sep 4, 2024 | AwardD | 96,210 | 0.00 USD | $0 | SEC |
| Aug 8, 2024 | AwardD | 50,000 | 0.00 USD | $0 | SEC |
| Jul 16, 2024 | ExerciseD | -11,235 | 0.00 USD | $0 | SEC |
| Jul 16, 2024 | Exercise | 16,505 | 4.34 USD | $71.6K | SEC |
| Jul 16, 2024 | ExerciseD | -5,270 | 0.00 USD | $0 | SEC |
| Jul 2, 2024 | Exercise | 10,000 | 15.60 USD | $156K | SEC |
| Jul 2, 2024 | Sell | -6,599 | 58.55 USD | $386.4K | SEC |
| Jul 2, 2024 | Sell | -1,803 | 59.56 USD | $107.4K | SEC |
| Jul 2, 2024 | Sell | -1,854 | 59.48 USD | $110.3K | SEC |
| Jul 2, 2024 | ExerciseD | -10,000 | 0.00 USD | $0 | SEC |
| Jul 2, 2024 | Sell | -8,146 | 58.41 USD | $475.8K | SEC |